Literature DB >> 18465725

Five-year results of viscocanalostomy.

V P David1, K G Kutty, N Somasundaram, A M Varghese.   

Abstract

PURPOSE: To prospectively study the success rates and complications of viscocanalostomy.
METHODS: Prospective nonrandomized case series of 46 eyes (46 patients) with medically uncontrolled primary and secondary open angle glaucoma. All patients in the study underwent viscocanalostomy. Control of intraocular pressure was used to measure success. Pre and postoperative glaucoma medications, visual acuity, complications, and adjunctive procedures were recorded.
RESULTS: At 60 months, qualified success (intraocular pressure below 21 mmHg with glaucoma medication) was achieved in 37 (82%) patients and complete success (intraocular pressure below 21 mmHg without medication) in 25 (54%) patients. Nd:YAG laser goniopuncture was performed in 33 (72%) patients with significant post laser reduction of intraocular pressure. No sight threatening complications were observed in this series. Visual acuity remained unchanged in 33 patients (72%).
CONCLUSIONS: Viscocanalostomy appears to be a safe and effective intraocular pressure lowering procedure in eyes with primary open angle glaucoma and certain types of secondary open angle glaucoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18465725     DOI: 10.1177/112067210801800316

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  10 in total

1.  Meta analysis of non-penetrating trabecular surgery versus trabeculectomy for the treatment of open angle glaucoma.

Authors:  Min Ke; Jing Guo; Zhigang Qian
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-04-20

2.  Exit strategies in canaloplasty: intraoperative conversion into 180-degree trabeculotomy or 360-degree trabeculotomy in cases of unsuccessful catheterisation of Schlemm's canal: influence of degree of canal cleavage.

Authors:  Omar Alnahrawy; Gunnar Blumenstock; Focke Ziemssen; Peter Szurman; Martin Alexander Leitritz; Spyridon Dimopoulos; Bogomil Voykov
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-02-18       Impact factor: 3.117

3.  Viscocanalostomy combined with trabeculotomy and mitomycin C in the treatment of primary congenital glaucoma.

Authors:  Chao-Xu Qian; Yuan Zong; Qin Chen; Zhi-Lan Yuan
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

4.  Long-term results of viscocanalostomy and phacoviscocanalostomy: a twelve-year follow-up study.

Authors:  Uzeyir Gunenc; Taylan Ozturk; Gul Arikan; Nilufer Kocak
Journal:  Int J Ophthalmol       Date:  2015-12-18       Impact factor: 1.779

5.  [Non-penetrating glaucoma surgery].

Authors:  T Klink; J Matlach; F Grehn
Journal:  Ophthalmologe       Date:  2012-08       Impact factor: 1.059

Review 6.  Recent Advances in the Surgical Management of Glaucoma in Exfoliation Syndrome.

Authors:  Mohamed S Sayed; Richard K Lee
Journal:  J Glaucoma       Date:  2018-07       Impact factor: 2.503

7.  Combined phacoemulsification and viscocanalostomy with Ologen implant versus combined phacoemulsification and viscocanalostomy.

Authors:  Ahmed A M Gad; Bahaa-Eldin Hasan Abdulhalim; Ayman Lotfy; Ayman Mohamed Abdelrahman; Ahmed Samir Ahmed
Journal:  BMC Ophthalmol       Date:  2019-02-06       Impact factor: 2.209

8.  Viscocanalostomy and combined phacoemulsification with viscocanalostomy: A five-year follow-up.

Authors:  Conor M Lyons; Daniela Oehring; Divya Mathews
Journal:  Indian J Ophthalmol       Date:  2022-01       Impact factor: 1.848

9.  Laser intervention on trabeculo-Descemet's membrane after resistant viscocanalostomy: Selective 532 nm gonioreconditioning or conventional 1064 nm neodymium-doped yttrium aluminum garnet laser goniopuncture?

Authors:  Huri Sabur; Mehmet Baykara; Basak Can
Journal:  Indian J Ophthalmol       Date:  2016-08       Impact factor: 1.848

10.  The efficacy of Viscocanalostomies and combined phacoemulsification with Viscocanalostomies in the treatment of patients with glaucoma: a non-randomised observational study.

Authors:  Andrew Want; Derek K-H Ho; Bhavani Karri; Divya Mathews
Journal:  BMC Ophthalmol       Date:  2018-05-02       Impact factor: 2.209

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.